Cartesian Therapeutics to Join Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 26, 2024 -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage biotechnology firm that specializes in mRNA cell therapy for autoimmune diseases, has made significant announcements regarding its participation in upcoming investor events. The management team is scheduled to present at two notable conferences in September.

First, the company will be involved in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference. This event is scheduled for Monday, September 9, 2024, at 2:30 p.m. ET in New York, NY. The second appearance will be at the Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 9:45 a.m. ET, also in New York, NY.

These fireside chats are expected to be accessible via live webcast through the Events section of Cartesian Therapeutics' official website. The company also plans to provide an archived replay of these events for a limited period, allowing stakeholders and interested parties to review the discussions at their convenience.

Cartesian Therapeutics is at the forefront of developing innovative mRNA cell therapies aimed at treating autoimmune diseases. The company's leading product, Descartes-08, is an mRNA CAR-T therapy currently in Phase 2b clinical trials for generalized myasthenia gravis. Additionally, Descartes-08 is in Phase 2 development for treating systemic lupus erythematosus, with future plans for a Phase 2 basket trial to explore additional autoimmune conditions.

In addition to Descartes-08, Cartesian Therapeutics' pipeline includes another promising candidate, Descartes-15. This next-generation, autologous anti-BCMA mRNA CAR-T therapy demonstrates the company's commitment to advancing innovative treatments for complex diseases.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!